MORGAN BRIDGES: Open Payments
NPI 1518798347 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 25 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $239 · 2025 $751
Food & beverage: $652Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $126 |
| Astellas Pharma US Inc | 4 | $121 |
| Legend Biotech USA Inc. | 1 | $53 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Stemline Therapeutics Inc. | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $31 |
| PFIZER INC. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $28 |
| KYOWA KIRIN, INC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
Products named: IMBRUVICA, Xospata, CARVYKTI, PREVYMIS, Cresemba, ELZONRIS, TECVAYLI, ELREXFIO.
Industry payments across TX — which companies pay providers there.
